Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial

Published:2018 Issue:9 Volume:9 Page:4763-4770
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Mafi Alireza¹²³⁴^ORCID,Namazi Gholamreza¹²³⁴,Soleimani Alireza⁵²³⁶,Bahmani Fereshteh⁵²³⁶,Aghadavod Esmat⁵²³⁶,Asemi Zatollah⁵²³⁶^ORCID

Affiliation:

1. Research Center for Biochemistry and Nutrition in Metabolic Diseases

2. Kashan University of Medical Sciences

3. Kashan

4. I.R. Iran

5. Department of Internal Medicine

6. Iran

Abstract

This study was carried out to evaluate the effects of probiotics administration on the metabolic and genetic profiles in patients with diabetic nephropathy (DN).

Funder

Kashan University of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/FO/C8FO00888D

Reference49 articles.

1. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

2. Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria

3. Endothelial dysfunction as a potential contributor in diabetic nephropathy